Naggirinya, Agnes Bwanika
Nuwamanya, Elly
Nabaggala, Maria Sarah
Musinguzi, Francis
Nanungi, Annet
Waiswa, Peter
Rujumba, Joseph
Meya, David B.
Parkes-Ratanshi, Rosalind
Article History
Received: 27 January 2024
Accepted: 1 July 2024
First Online: 20 September 2024
Declarations
:
: This study was approved by the Makerere University School of Medicine Higher Degrees Research Ethics Committee (REC Ref 2019–083) and the Uganda National Council of Science and Technology (Ref HS 576ES). All participants gave written informed consent.
: N/A.
: RPR discloses that Infectious Diseases Institute received research funding from Janssen, the Pharmaceutical Companies of Johnson and Johnson for work on Call for Life and other research projects. Other authors report no competing interests.